for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Inovio's potential COVID-19 vaccine trial on partial clinical hold

Sept 28 (Reuters) - Inovio Pharmaceuticals Inc said on Monday the U.S. Food and Drug Administration had placed a partial clinical hold on the company’s planned mid-to-late-stage trial of its experimental coronavirus vaccine candidate.

The company said the pause was not due to any side effects in its early-stage study of the vaccine.

The FDA had additional questions, including about the vaccine delivery device to be used in the study, Inovio said. (Reporting by Manas Mishra in Bengaluru; Editing by Shinjini Ganguli)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up